Is pharma putting all of its eggs in one COVID basket? Siera Torontow considers pharma’s success in dealing with ESG (Environmental, Social and Governance) issues and the impact on reputation Read More
Has pharma missed the boat? Analysis of how the pharmaceutical sector is viewed through its Environmental, Social and Corporate Governance (ESG) actions indicates that the moment for reputational enhancement might be passing Read More